Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Gastroparesis affects some users of these diabetes and weight-loss drugs, causing symptoms including nausea, vomiting, early fullness, bloating, and reduced appetite
Diabetes 69 , 267268 (2020)
72 ShalemO.SanjanaN
Demographic breakdown shows that patients aged 40-65 represent the largest segment of GLP-1 users, though prescription rates are rising notably in younger adults seeking preventive metabolic support
Stability & Storage Refer to research notes Molecular Data Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Formula C62H98N16O22 Molecular Weight 1419.5 g/mol CAS Number 137525-51-0 IUPAC Name N-(1-Oxo-3-propyl)-L-prolyl-L-prolyl-L-prolyl-L-glycyl-L-lysyl-L-prolyl-L-alanyl-L-aspartyl-L-aspartyl-L-alanyl-L-glycyl-L-leucyl-L-valylamide Primary literature:
Scand J Immunol
US$ 23.14
US$ 21.97
US$ 22.92
US$ 20.74
US$ 21.57
US$ 26.69
US$ 27.91
US$ 21.74
US$ 21.49
US$ 23.80
